Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K N Naresh

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Leukemia & Lymphoma|May 10, 2002
Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implicationsK N Naresh, S D Banavali, K G Bhatia, et al.
Indian Journal of Cancer|December 1, 1992
Extranodal sinus histiocytosis with massive lymphadenopathy--a case reportK N Naresh, G Mukherjee, C R Rao, et al.
Breast (Edinburgh, Scotland)|January 21, 2004
Hormone receptor status of breast cancer in India: a study of 798 tumoursS B Desai, M T Moonim, A K Gill, et al.
Leukemia & Lymphoma|May 26, 1999
Expression of Fas and Fas ligand in Hodgkin's diseaseS S Metkar, K N Naresh, A A Redkar, et al.
Leukemia & Lymphoma|December 29, 1999
MALT lymphoma of nasal mucosa treated with antibioticsS Gupte, R Nair, K N Naresh, et al.
Histopathology|June 27, 2007
Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patientsF Amen, D Horncastle, K Elderfield, et al.
Histopathology|March 23, 2007
Total CD34+ cells per 10 HPF in bone marrow trephines of patients with chronic myeloid leukaemia correlates with probability of complete cytogenetic response following imatinib treatmentV Elliot, D Marin, D Horncastle, et al.
Cancer Genetics and Cytogenetics|October 17, 1998
Translocation (11;14)(q13;q32) and overexpression of cyclin D1 protein in a CD23-positive low-grade B-cell neoplasmG Nanjangud, K N Naresh, C N Nair, et al.
Indian Journal of Cancer|March 1, 1994
Carcinoma of the urinary bladder metastatic to the oral cavityD C Doval, K N Naresh, K S Sabitha, et al.
Journal of Clinical Pathology|October 29, 2009
The significance of tumour cell immunophenotype in myeloma and its impact on clinical outcomeN-T Ngo, C Brodie, C Giles, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|May 10, 2002
Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implicationsK N Naresh, S D Banavali, K G Bhatia, et al.
Indian Journal of Cancer|December 1, 1992
Extranodal sinus histiocytosis with massive lymphadenopathy--a case reportK N Naresh, G Mukherjee, C R Rao, et al.
Breast (Edinburgh, Scotland)|January 21, 2004
Hormone receptor status of breast cancer in India: a study of 798 tumoursS B Desai, M T Moonim, A K Gill, et al.
Leukemia & Lymphoma|May 26, 1999
Expression of Fas and Fas ligand in Hodgkin's diseaseS S Metkar, K N Naresh, A A Redkar, et al.
Leukemia & Lymphoma|December 29, 1999
MALT lymphoma of nasal mucosa treated with antibioticsS Gupte, R Nair, K N Naresh, et al.
Histopathology|June 27, 2007
Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patientsF Amen, D Horncastle, K Elderfield, et al.
Histopathology|March 23, 2007
Total CD34+ cells per 10 HPF in bone marrow trephines of patients with chronic myeloid leukaemia correlates with probability of complete cytogenetic response following imatinib treatmentV Elliot, D Marin, D Horncastle, et al.
Cancer Genetics and Cytogenetics|October 17, 1998
Translocation (11;14)(q13;q32) and overexpression of cyclin D1 protein in a CD23-positive low-grade B-cell neoplasmG Nanjangud, K N Naresh, C N Nair, et al.
Indian Journal of Cancer|March 1, 1994
Carcinoma of the urinary bladder metastatic to the oral cavityD C Doval, K N Naresh, K S Sabitha, et al.
Journal of Clinical Pathology|October 29, 2009
The significance of tumour cell immunophenotype in myeloma and its impact on clinical outcomeN-T Ngo, C Brodie, C Giles, et al.
Pageof 11